Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
Is HHS Committed to Lowering Drug Prices?
On Tuesday, June 12, 2018, United States Health and Human Services (HHS) Secretary Alex Azar appeared before the United States…
FDA Publishes List of Drug Companies Allegedly Blocking Access to Drug…
The United States Food and Drug Administration (FDA) has recently publicized a list of forty-one branded drug companies that have…
Senate Holds Hearing on Pricing of Insulin
On Tuesday, May 8, 2018, the Senate Special Committee on Aging held a hearing entitled, “Insulin Access and Affordability: The…
Vermont’s Next Act: Wholesale Prescription Drug Importation Program
With Vermont Governor Phil Scott’s (R) signature on Senate Bill 175, Vermont now becomes the first-in-the-nation to enact a…
President Trump Gives Remarks on Lowering Drug Prices
“We will see those prices go down, it will be a beautiful thing to watch.” President Donald J. Trump
In less than twenty-five…
Circuit Court Strikes Blow to Maryland Drug Pricing Measure
On April 13, 2018, the United States of Appeals for the Fourth Circuit struck down the first-in-the-nation law aimed at lowering…
Physician Specialty Groups Caution Against Proposed Drug Pricing Changes
Nine of the nation’s leading physician groups – including the American College of Rheumatology, American Academy of…
How Can We Increase Value and Monitor / Lower Costs?
Health Affairs and the National Pharmaceutical Council held a briefing focused on efforts to increase value and monitor costs on…
Senate Holds Hearing on 340B Drug Pricing Program
On Thursday, March 15, 2018, the United States Senate Committee on Health, Education, Labor & Pensions held a hearing…
Higher Outpatient Drug Spending At 340B Hospitals, According to New…
A new analysis finds that hospitals which participate in the 340B Drug Discount Program have higher per patient outpatient…